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Abstract: The mucus produced by many marine organisms is a complex mixture of proteins 
and polysaccharides forming a weak watery gel. It is essential for vital processes including 
locomotion, navigation, structural support, heterotrophic feeding and defence against a 
multitude of environmental stresses, predators, parasites, and pathogens. In the present study 
we focused on mucus produced by a benthic cnidarian, the sea anemone Actinia equina 
(Linnaeus, 1758) for preventing burial by excess sedimentation and for protection. We 
investigated some of the physico-chemical properties of this matrix such as viscosity, 
osmolarity, electrical conductivity, protein, carbohydrate, and total lipid contents. Some 
biological activities such as hemolytic, cytotoxic, and antibacterial lysozyme-like activities 
were also studied. The A. equina mucus is mainly composed by water (96.2% ± 0.3%), 
whereas its dry weight is made of 24.2% ± 1.3% proteins and 7.8% ± 0.2% carbohydrates, 
with the smallest and largest components referable to lipids (0.9%) and inorganic matter 
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(67.1%). The A. equina mucus matrix exhibited hemolytic activity on rabbit erythrocytes, 
cytotoxic activity against the tumor cell line K562 (human erythromyeloblastoid leukemia) 
and antibacterial lysozyme-like activity. The findings from this study improve the available 
information on the mucus composition in invertebrates and have implications for future 
investigations related to exploitation of A. equina and other sea anemones’ mucus as a source 
of bioactive compounds of high pharmaceutical and biotechnological interest. 
Keywords: mucus; Actinia equina; antibacterial activity; hemolytic activity; cytotoxicity; 
tumor cell line K562 
 
1. Introduction 
To adhere on immersed substrata in their aquatic habitats, many marine organisms, including 
invertebrates, secrete viscoelastic adhesive gels such as mucus consisting primarily of a network of 
polysaccharides and proteins entangled to form a weak gel containing more than 95% water [1–4]. 
Different from synthetic glue polymers, these bio-molecules are produced in an aqueous environment, 
therefore including water as a key constituent [5]. This represents a major difference between natural 
adhesive and synthetic polymers. Mucus is essential to several aquatic organisms for various reasons, 
e.g., to reduce drag forces, prevent sedimentation, enhance adhesion, limit water loss, and facilitate 
locomotion [6]. In addition mucus can serve as a “scaffolding” that provides anchorage and protection 
for egg-laying and a barrier against infection [3]. A mucus layer indeed provides a physical shield [7] 
and a slippery coating that prevents bacteria and debris from accumulating on the body surface [8], with 
a number of defence mechanisms [9–13]. Many marine invertebrates are sessile, i.e., steadily attached to 
the sea bottom or with low locomotion ability, thus vulnerable either to predation and threat from a rich 
surrounding microbiota with pathogenic potential. Besides mechanical protection, the mucus of many 
invertebrates contains specific compounds to make the animal poisonous, distasteful or irritating, or a 
combination of these features [14]. Also, it is not surprising that these invertebrates developed an innate 
immune system producing a considerable number of defence molecules such as lytic compounds [15], 
bioactive antimicrobials [16–18], toxins, and carbohydrate antiadhesives [19]. Lectin-like molecules 
able to agglutinate red blood cells were characterized from mucus of the gastropod snail Helix aspersa, 
whose agglutinating activity was inhibited by D-Ga1NAc [20]. In addition, the potential to reduce the 
bacterial adhesion was demonstrated from mucus glycoproteins of the starfish Marthasterias glacialis [21], 
together with an antibacterial lysozyme-like activity [22], also observed in the annelid polychaetes 
Sabella spallanzanii [10,23] and Myxicola infundibulum [12]. 
As suggested by Calow [24], mucus could be made more or less susceptible to microbial attack. Some 
invertebrates could lace their mucus with antibiotic molecules when it is more advantageous for them to 
inhibit bacterial attack; in those cases, the mucus contains less proteins and does not promote bacterial 
growth. By contrast, some invertebrates, including corals [25], may release mucus with high content of 
proteins rapidly used by microbes. Due to their high turnover rates and their physiological diversity, 
microbes are likely to react quickly to released protein-rich mucus. Bacteria indeed possess a wide range 
of exo-enzymes potentially capable of degrading mucoid polymers, boosting the development of a 
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mucus-specific microbiome. These microbes may transform mucus-derived (dissolved and particulate) 
organic matter into living biomass, i.e., forming the so-called “microbial loop” trophic pathway [26], 
where mucus can be the scaffolding matrix eventually supporting a mucus-based food web [27–29]. 
Most cnidarians, including both medusozoans and anthozoans, are capable of secreting a mucus-
based surface layer essential for a number of processes such as feeding, protection against pathogens, 
desiccation, and a number of environmental stresses. Mucus production may account for as much as 40% 
of the net daily fixed carbon in the coral Acropora acuminata [30]. Other uses that should be considered 
are protection from aggression and as an offensive weapon. The coral Lobactis (Fungia) scutaria in 
response to contact with other corals or rough human handling secretes mucus containing cytotoxic 
molecules to other corals. A highly active cytolysin as well as aliphatic-antibiotic compounds have been 
isolated from the mucus secretion of the sea anemone Heteractis magnica [31]. In spite of the multitude 
of ecological and physiological roles played by the cnidarian mucus, relatively little is known about the 
link between biochemical structures and functions. In the present study we focused on the mucus of the 
intertidal sea anemone Actinia equina produced as mechanical protection against excess sedimentation 
or desiccation as well as barrier against microbial attacks. Tissue extracts of A.equina has been long 
investigated for their peptide and protein toxins. Besides at least five isoforms of pore-forming cytolysins 
(equinatoxins) of proteinic nature, tissues of A. equina also contain several peptide toxins (Ae I, Ae K, 
acrorhagin I and II) isolated from different body portions [32,33]. Here, we investigated some of the 
physico-chemical properties of the secreted mucus of A. equina such as viscosity, osmolarity,  
electrical conductivity, protein, carbohydrate, and total lipid contents. Some biological activities,  
such as the hemolytic, cytotoxic, and antibacterial lysozyme-like activities were also investigated to  
highlight the potential of sea anemone mucus as a source of bioactive compounds of interest for  
biotechnological applications. 
2. Results 
2.1. Mucus Viscosity, Osmolarity, and Electrical Conductivity 
Adult specimens of A. equina were employed for both the study of the physical and chemical 
properties of the mucus and the determination of its biological activities. The mean viscosity of  
A. equina mucus was 2.1 ± 0.02 cPs in respect to the 1 cPs viscosity of water measured at 20 °C  
(Table 1). The mean osmolarity value of the cnidarian mucus was 1205 ± 10 mOsmol/L, similar to seawater 
(1152 ± 25 mOsmol/L). The mean electrical conductivity of mucus was 124 ± 4 mS·cm−1 whilst the 
electrical conductivity of the seawater is 35 mS·cm−1. 
Table 1. Main physico-chemical characteristics of Actinia equina mucus. 
Physico-Chemical Feature  Mean ± SD
Inorganic matter (%) 67.1 ± 2.3
Organic matter (%) 32.9 ± 0.2
Viscosity 20 °C (cps) 2.1 ± 0.02
Osmolarity (mOsmol/L) 1205 ± 10
Conductivity (mS·cm−1)  124 ± 4.0
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2.2. Water and Inorganic Content 
The water content of A. equina mucus was 96.1% ± 0.5% (Figure 1A). After dehydration, inorganic 
salts represented the main part (67.1% ± 2.3%) of the mucus dry weight (DW) (Figure 1B). Mean 
percentages of the elements are listed in Table 2: In all samples, Cl and Na were abundant whereas C, 
Mg and K represented only 2.8%–2.1% of the inorganic content. 
 
 
Figure 1. Actinia equina mucus composition: (A) water content and dried weight; (B) organic 
and inorganic residuals. 
Table 2. Elements detected in mucus sample of Actinia equine. 
Element Content (%) 
Cl 44.48 ± 0.12 
Na 13.38 ± 0.11 
Mg 2.41 ± 0.03 
H 1.53 ± 0.10 
K 2.11 ± 0.02 
Ca 0.71 ± 0.02 
C 2.13 ± 0.02 
N 0.45 ± 0.02 
Zn 0.06 ± 0.005 
Cu absent 
Fe absent 
P absent 
Se absent 
Sn absent 
  
Water
96.1%
Dry weight 
3.9%
A
Total proteins 
24.2%
Total lipids 
0.9%Carbohydrates 
7.8%
Inorganic 
67.1%
B
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2.3. Protein, Carbohydrate, and Lipids Concentration 
The organic residual of A. equina mucus DW was composed of proteins (24.2% ± 1.3%), 
carbohydrates (7.8% ± 0.2%) and lipids (0.9% ± 0.02%) (Figure 1B) with protein/glucose ratio equals  
to 3.2. The electrophoretic analysis revealed at least fourteen major protein bands, ranging from 12 to  
200 kDa (Figure 2B). 
 
Figure 2. SDS-PAGE analysis of Actinia equina mucus. Panel A: Molecular weight 
standards furnished by Fermentas. Molecular weights (kDa) of standard proteins are on left; 
Panel B: A. equina total mucus; (C) Actinia equina different molecular weight fractions from 
total mucus extract obtained by membrane filtration system (pore size: 10 kDa). SDS-PAGE 
15% acrylamide gel stained with Coomassie Blue R-250. Lane 1: Fraction >10 kDa named 
“U” (Upper), Lane 2: Standard Low sigma, Lane 3: Fraction <10 kDa. Named “D” (Lower); 
(D) Micro plate lysis assay carried out against Rabbit erythrocytes (RRBCs) in TBS buffer. 
Hemolysis is evidenced by free hemoglobin, when the erythrocytes are not lysed a central 
pellet of erythrocytes is visible on the well center. Lower fraction (D) showing lysis until 
dilution of 1:64, Upper fraction (U) showing lysis until dilution of 1:2048, Control experiment 
(Ce) with RRBCs and buffer. 
2.4. Lysozyme Like Activity 
Mucus of A. equina showed a natural lysozyme like activity (Figure 3A). This activity was strictly 
affected by pH (Figure 3B) and ionic strength (I) (Figure 3C) of the sample and of the reaction medium. 
The maximum diameter of lysis was reported at pH 6.0. The lytic activity increased after dialysis of the 
mucus at pH 6.0 and I = 0.175. The largest diameters of lysis were recorded at 37 °C (Figure 3D). By 
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the standard assay on Petri dishes the maximum diameter of lysis (16.2 ± 0.5 mm corresponding to  
2.21 mg/mL of hen egg-white lysozyme) was reported at I = 0.175, pH 6.0 and incubation temperature 
of 37 °C. 
 
Figure 3. Lysozyme-like activity of Actinia equina mucus. (A) Standard assay on Petri  
dish inoculated with Micrococcus lysodeikticus cell walls to detect the lysozyme-like activity 
of A. equina mucus; (B) Effect of the pH on the lysozyme-like activity of A. equina mucus. 
Columns are mean values (n = 20) (vertical bars ± Standard Deviation); (C) Effect of the 
ionic strength on the lysozyme-like activity of mucus. Columns are mean values (n = 20) 
(vertical bars ± Standard Deviation); (D) Effect of the incubation temperature on the 
lysozyme-like activity of mucus. Columns are mean values (n = 20) (vertical bars ± Standard 
Deviation). 
2.5. Hemolytic Activity 
Mucus of A. equina with a protein concentration of 0.8 mg/mL exerted a hemolytic effect after incubation 
at 37 °C against rabbit and sheep erythrocytes with a lysis titer of 1:526 and 1:1048, respectively. 
2.6. Cytotoxic Activity 
The trypan blue dye exclusion test was used to determine the number of viable cells present in a cell 
suspension incubated with A. equina mucus sample. Human erythromyeloid leukemia-derived (K562) 
treated cells were damaged by mucus compounds (Figure 4A). Control cells (without mucus incubation) 
show intact cell membranes and do not incorporate trypan blue (Figure 4B). 
The mucus of A. equina exhibits direct cytotoxic activity on K562 target cells (Figure 4C). Lactate 
dehydrogenase release into the supernatant of cells was used to calculate the percentage of target cell 
lysis. At the mucus protein concentration of 0.8 mg/mL and 0.4 mg/mL, the percentage of lysis was 
found significantly higher than control cells and quantified respectively equal to 62% and 58% of total 
target cells in suspension. 
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Figure 4. (A) Light Microscopic observation of Human erythromyeloblastoid leukemia 
(K562) cells treated with A. equine mucus crude extract. The target cell lysis was also determined 
by trypan blue exclusion test. Bar: 25 μm; (B) Control cell observed in the absence of mucus 
Bar. 25 μm; (C) Colorimetric assay of A. equina mucus extract on human chronic myelogenous 
leukemia cells K562 (Cytotoxic detection Kit. Boehringer Mannheim, Mannheim, Germany). 
Lactate dehydrogenase release into the supernatant was used to calculate the percentage of 
target cell lysis. 
2.7. Fractionation of Actinia Equina Mucus 
The system of separation by centrifugation through Nanosep devices membrane has allowed to obtain 
two fractions starting from the sample of mucus (1.2 ± 0.3 mg/mL). Molecules larger than the membrane 
pores of 10 kDa were retained at the surface of the membrane and concentrated during the ultrafiltration 
process. This component was defined “U” (upper) with a concentration of 1.5 ± 0.2 mg/mL, while the 
fraction with molecular weight below 10 kDa was named “D” (lower) (0.256 ± 0.022 mg/mL). The SDS 
electrophoresis analysis of the two mucus components showed a major component to occur in the D 
fraction, with an apparent mass less than 6 kDa (Figure 2C). 
In microplate the isolated fractions showed a different lytic activity toward rabbit erythrocytes  
(Figure 2D). The lysis capacity was identified until 1:2048 dilution of the sample in the U fraction, and 
till dilution of 1:64 in the D fraction. 
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Figure 5. (A) High performance liquid chromatography separation of A. equina mucus 
components. The first plot shows profile of HPLC analysis of the crude mucus extract. Green 
arrows 1 and 2 indicate the isolated peaks at 12.5 and 14.5 min. Insert shows HPLC profiles 
of bovine serum albumin (BSA-66 kDa), chimotrypsinogen (25 kDa) and ribonuclease  
(13.7 kDa) used as standards separated on a molecular weight exclusion column BioSuite 
250 (10 microns; Waters, Milford, CT, USA). The second plot shows the purification profiles 
of the high molecular weight fraction (u = upper) and low molecular weight fraction  
(d = lower) previously separated via centrifugation system on 10 kDa membrane. Red arrow 
indicate peak 2 detected at 14.5 min post HPLC start running; (B) Lytic activity detected in 
microplate toward rabbit erythrocytes of peaks 1 and 2 (Ce: Control experiment). 
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2.8. HPLC Separation of Mucus Components 
Profiles of high pressure liquid chromatography (HPLC) on a column of size exclusion chromatography 
(BioSuite 250, 10 μm SEC, 7.5 mm × 300 mm) revealed the separation plot obtained from the mucus 
sample and the U fraction to be similar (Figure 5A). Two peaks are detected at 12.5 min (1) and  
14.5 min (2). The first one contains proteins with a high molecular weight while the second peak includes 
molecules of lower dimensions. The profile of purification of the D fraction resulted enriched in the second 
component of low molecular weight. All the HPLC fractions of 1 mL/min were collected and subsequently 
analyzed to assess the hemolytic activity. The results of the assays (Figure 5B) showed the presence of 
hemolytic activity toward rabbit erythrocytes up to 1:16 for the peak 1 and 1:32 for the peak 2. Thus, different 
components within the sample showed similar hemolytic activity. Comparing the elution volume of 
standards used before purification of samples, the fraction 1 contains mainly a 20 kDa electrophoretic 
band while the peak 2 includes the 6 kDa component. The nature of equinatoxins-related activity of the 
20 kDa fraction was suggested by inhibition experiments using bovine sphingomyelin (data not shown). 
One of the hallmarks of actinoporins is they efficiently make pores in lipid membranes containing this 
lipid. Thus, the interaction between erythrocytes membrane lipids and lysins was evaluated by inhibition 
experiments carried out using rabbit erythrocytes. 
3. Discussion 
Underwater attachment will undoubtedly have many technological applications including the design 
of water-resistant adhesives, sealants, and biomedical coatings and the development of new antifouling 
strategies [34]. Nonetheless a considerable dearth of information still remains regarding the biochemical 
composition of marine adhesives and the link between biochemical structure and function. Hitherto, 
studies on adhesives from invertebrates mainly concerned the characterization of permanent secretions 
from mussels and barnacles [5,35]. In comparison, non-permanent adhesives, (more hydrated than 
permanent ones and consisting of a mixture of proteins and polysaccharides) received so far much less 
attention [4,36–39]. The present paper represents a preliminary contribution on this topic since we 
provide novel data on the physico-chemical and biological properties of the sea anemone A. equina 
mucus. We analyzed some rheological properties of mucus such as osmolarity and viscosity since they 
are believed to be critical in fulfilling specific biological functions and are intimately related to the 
chemical composition [23]. Compared to mucus from typical marine sources [40] with a water content 
ranging 96%–98% of the wet weight, the mucus of A. equina has water content up of 96.2% ± 0.3%. 
The high percentage of inorganic material (about 67.1%) presumably results from dried salts left  
over when the seawater in a gel evaporates as already suggested for limpets and periwinkles mucus by 
Smith et al. [4] and Smith and Morin [40] which observed a similar proportion of inorganic material. 
The mucus of the studied cnidarian is mostly composed of proteins, representing the most conspicuous 
organic component (24% of total mucus dry matter, 73% of dry organic matter residual), and 
carbohydrates (7.8% of total mucus dry matter, near 24% of dry organic matter residual). Similar values 
were recorded for the mucus of limpets [4] as well as for the mucus of the annelid polychaete Sabella 
spallanzanii [10]. From studies on the biochemical composition of adhesive footprints of the sea star 
Asterias rubens [41,42] the amount of protein and carbohydrate (20% and 8% respectively) resulted 
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similar to those recorded in A. equina mucus. As observed in the mucus of A. equina, the co-occurrence 
of proteins and carbohydrates seems to be a common trait among non-permanent adhesives of marine 
invertebrates, from cnidarians to deuterostomes [37] and protostomes [40,43]. These protein-carbohydrate 
complexes typically form highly hydrated adhesives with viscoelastic properties [42,43]. The mucus  
of A. equina corresponds to this kind of adhesives also on account of the obtained values of viscosity  
and osmolarity. This matrix indeed exhibits a low viscosity (2.1 ± 0.02 cps) and its osmolarity is of the  
same order of magnitude as the seawater such that mucus achieves near ionic equilibrium with the 
surrounding medium. 
A noteworthy result of the present paper is the protein pattern of the A. equina mucus: from the 
electrophoretic analysis a complex of at least fourteen major proteins ranging from 12 to 200 kDa was 
highlighted. This is in agreement with the general multi-protein nature of other marine invertebrate 
adhesives. Indeed, in the sea urchin Paracentrotus lividus footprint material SDS-PAGE analysis 
revealed that the soluble fraction contains about 13 protein bands with molecular masses ranging from 
10 to 200 kDa [39]. Moreover, in the mucus of the polychaete Sabella spallanzanii the electrophoretic 
analysis revealed at least 10 major protein bands, with molecular weights ranging from 16 to 90 kDa, 
and six minor components, with molecular weights ranging from 14 to 116 kDa [23]. In non-permanent 
adhesives, multi-protein complexes have been also evidenced in sea cucumbers and limpets [34,43]. The 
lysozyme activity recorded in mucus of A. equina mucus can be ascribed to one the fourteen major 
protein bands evidenced by electrophoretic analysis. Interestingly, one of the “known proteins in the 
databases” described in a marine adhesive is a homolog of lysozyme in barnacle cement [44]. Lysozyme 
represents the best characterized enzyme involved in self-defence from bacteria [45]. This enzyme is  
a glycoside hydrolase and dissolves certain bacteria by hydrolyzing the glycosidic β1-4 bonds between 
N-acetylglucosamine and N-acetylmuramic acid of bacterial cell walls. A bacterial cell devoid of a wall 
usually bursts because of the high osmotic pressure inside the cell. The constitutive levels of lysozyme 
protect the organism from bacteria living in the same environment and control its natural symbiotic flora. 
Lysozyme-like proteins have also already been found in other cnidarians, including some species of sea 
anemones [46,47]. In the present work it a lysozyme-like activity was also highlighted in the mucus of 
A. equina. This lysozyme had a maximum of activity when the pH of the reaction medium and sample 
was 6 and the ionic strength 0.175, as previously reported for other lysozymes [48–52]. 
We also showed hemolytic activity of A. equina mucus extract toward RRBC target cells. After 
purification by membrane separation system and HPLC, different components exhibiting hemolytic 
activity have been found. Among the mucus components of high molecular weight, fraction “up”, the 
hemolytic activity resides in a 20 kDa protein corresponding to Equinatoxin, as demonstrated by the 
experiment of hemolysis carried out on peaks isolated by HPLC. Results of hemolytic assays showed 
also an active fraction with a lowest molecular weight, of approximately 6 kDa in SDS. Both these lytic 
fractions are inhibited by sphingomyelin. This suggests that the mucus of A. equina could contain 
actinoporin-like molecules, known to be specifically inhibited by sphingomyelin [53] which may have 
an interaction with erythrocyte membrane permeability, leading to lysis. Actinoporins belong to the 
unique family of the α-pore-forming toxins (PFTs) due to their ability to hold the membrane 
phospholipids domains of the host organism forming cation selective pores [54]. Interestingly, the mucus 
of Heteractis magnifica showed a strong hemolytic activity toward fish erythrocytes, and exerted an 
antibacterial activity towards pathogenic bacterial strains. The presence in A. equina mucus of a hemolytic, 
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cytotoxic activity and an antibacterial activity suggests that this matrix may provide a defensive tool for 
the cnidarian from microbial attacks serving as substrate into which the humoral substances are released. 
The role of mucus as a defence against potentially pathogenic microorganisms has been already 
demonstrated for the mucus of other marine invertebrates including corals [3,9]. The antibacterial 
functions of coral mucus are particularly well documented in the soft corals. Slattery et al. [55] demonstrated 
anti-microbial and anti-fouling activity in Antarctic soft corals also and suggested that, although mucus 
secretion in these species was low, it was likely to be important in preventing bacterial attachment to the 
coral surface. 
The results obtained in the present study not only improve the available information on the mucus 
composition in invertebrates, but also have implications for future studies aimed to the employment of 
A. equina mucus as source of compounds with antimicrobial lysozyme-like and antitumor activity of 
pharmaceutical and biotechnological interest. As regards pharmaceuticals, the ongoing explosion of 
antibiotic-resistant infections due to new opportunistic pathogen multidrug-resistant microbes continues 
to plague global health care. This clearly highlights the need for new antibacterial agents with fundamentally 
different modes of action than that of traditional antibiotics. The enormous demand has triggered 
worldwide efforts in developing novel antibacterial alternatives. Bacterial cell wall hydrolases (BCWH) 
are among the most promising candidates and lysozyme was recently chosen as a model protein. For the 
first time, this led a great opportunity for potential use of lysozyme in drug systems as a new 
antimicrobial agent [56,57]. A possible application of lysozyme, which is attracting considerable interest, 
is the use of this molecule in veterinary work and in aquaculture facilities in particular. The emergence 
of microbial diseases in aquaculture industries is of major concern implying serious financial loss. 
Therefore, A. equina mucus appears as a promising and valuable alternative source of lysozyme for drug 
development and the marine origin of this lysozyme represents an added value. Last but not least, indeed, 
the lysozyme produced by A. equina mucus is salt-stable and this feature makes it more suitable to be 
used to control fish or shellfish pathogens in mariculture in the case of antibiotic efficacy reduction due 
to high-salt conditions. 
The utilization of A. equina mucus to extract bioactive substances of pharmaceutical interest is 
encouraged also with the evidence of the cytotoxic activity against the tumor cell line K562. In A. equina 
the first indication about cytotoxicity of its venom due to equinatoxin action was elucidated by dye 
exclusion test on Ehrlich carcinoma and L1210 leukemia inoculated in mice [58]. In another study, crude 
extracts from nematocyst and surrounding tissues of the sea-anemone A. equina were tested on V79 
fibroblasts [59]. Moreover Isoform II of Equinatoxin (Eq. II) showed cytotoxic capability against human 
glioblastoma U87 and A172 cell lines [60]. Eq. II was found to affect the survival of U87 glioblastoma 
cells by a necrosis-like action and increasing lactate dehydrogenase (LDH) release [61]. On account of 
our results it seems that in addition to Eq. II a low molecular component, responsible for the toxicity to 
K562 tumor cells, is present in the mucus. This finding demonstrates that not only nematocysts or the 
granulocytes of A equina produce and release cytotoxins [62] but also the matrix outside of the body 
which, releasing toxic substances, is involved in defense mechanisms. 
Finally, the antibacterial and cytotoxic activity of A. equina mucus could be employed to avoid the 
settlement of bacteria, which is the primary colonizing process in marine biofouling development. 
Alternative marine technologies employing biogenic compounds that function as natural anti-settlement 
agents are sought taking into account that some compounds such as TBT, copper [63], and organic 
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biocides [64] used as antifouling agents in paints have been banned after 2008 [65–67]. Recently we 
have also purified new thermo-stable proteases and antimicrobial peptides from the body and tentacle of 
A. equina and Anemonia sulcata which were applied for biocleaning or controlling microbial growth on 
heritage objects [68]. In particular, the protease-containing fraction was tested for the hydrolysis of 
protein layers on old paintings. The cleaning protocol including sea anemone proteases offered a novel 
selective procedure preventing damage to the original materials constituting the heritage object. The 
fraction containing the antimicrobial peptide was used to control fungal growth during the restoration of the 
painting [68]. Bioactive molecules extracted from sea anemones’ mucus are currently under investigation. 
4. Experimental Section 
4.1. Animals and Samples Preparation 
Adult specimens of Actinia equina were collected at Porto Cesareo (Lecce, Italy, 40.25 N, 17.9 E) 
using SCUBA equipment. 
About 100 adult specimens of A. equina were collected and transferred to the laboratory. Here the 
sea anemones were washed with filtered (0.2 µm) sterile sea water and kept for 30 min in a Petri dish in 
order to stimulate the secretion of the mucus for both the study of its physico-chemical properties and 
the determination of its biological activities such as hemolytic, cytotoxic and antibacterial, lysozyme-like 
activities. Within the secreted mucus, we checked for trapped material by microscopic observations, 
whilst we excluded any contamination of other excretion products by pH measurements. Secreted mucus 
was collected and centrifuged at 12,000× g for 30 min at 4 °C. A previous work [10] showed that the 
protein content of the mucus varies between individuals. To avoid the introduction of this variable,  
in the present work the mucus of the whole group of 100 individuals was pooled into five samples  
(each pool collected from 20 sea anemones) which were stored at −80 °C until use. 
4.2. Mucus Viscosity, Osmolarity, Electrical Conductivity and Water Content 
Mucus viscosity was measured at 200 rpm in 1 mL aliquots with a cone-plate viscometer (cone angle 
of 1.565°, model LVT-C/P 42, Brookfield Engineering Laboratories, Middleboro, MA, USA) connected 
to a circulating water bath (Thermoline, Wetherill Park, Sydney, Australia) set at 17 ± 0.1 °C. Due to 
differences in temperature and equipment used between studies, comparison of viscosity data can be 
difficult without reference to a common, known viscosity. Thus, we documented the relative viscosity of 
mucus with respect to the viscosity of water, similar to Rosen and Cornford [69] and Cone [70]. The 
viscosity of water is 1 cP at 20 °C and it is only slightly dependent on temperature [71]. 
Osmolarity was measured using a VAPRO vapour pressure osmometer (model 5520, WESCOR, 
Logan, UT, USA), all measurements being carried out in triplicate. Electrical conductivity was measured 
using a GLP 31 conductimeter (Crison, Barcelona, Spain). 
For water content measurement, the wet weights of mucus of 15 samples (three replicates for each of 
the five groups of 20 individuals each) were measured on an analytical balance. They were then 
dehydrated in a SpeedVac, and their dry weight (DW) was measured. 
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4.3. Determination of the Inorganic Composition 
The inorganic composition was determined for each sample after lyophilization of sample solution at 
52 °C and 0.061 mbar using a LIO 5P CINQUEPASCAL freeze-dryer. 
C, H, and N analyses were performed using a 1106 Carlo Erba elemental analyzer, while an AA-6200 
Shimadzu atomic absorption flame emission spectrophotometer was used for the determination of Fe, 
Ca, Mg, Zn, Cu, K, Na. A P/N 206-17143 Shimadzu hydride vapor generator was coupled to the atomic 
absorption spectrophotometer in order to analyze the Sn and Se content. In general, each sample was 
mineralized to oxidize the organic fraction. To this end a weighted sample of the mucus (ca. 10 mg) was 
treated with HNO3 (1 mL) and H2SO4 96% w/w (2.5 mL) at high temperature until no more fumes were 
released. The residue was treated again with the acids two more times. The final liquid residue was 
dissolved in water to give a 100 mL solution. For each element a calibration curve was obtained by using 
standard solutions. The quantitative analysis of phosphorous was performed using an UV-1601 Shimadzu 
spectrophotometer according to the method reported in the literature [72,73]. A 785 DMP Metrohm Titrino 
was used for the quantitative determination of the inorganic chloride using a potentiometric determination. 
4.4. Lipid, Protein, and Carbohydrate Concentration 
Total lipids from each mucus sample were extracted according to the method of Folch et al. [74]. The 
mucus was homogenized with chloroform/methanol (2:1) to a final volume 20 times the volume of the 
mucus sample. After centrifugation and siphoning of the upper phase, the lower chloroform phase 
contained the lipids. Total lipid content was determined by the colorimetric enzymatic method [75] using 
commercial kit (FAR, Verona, Italy). 
The protein concentration of each mucus sample was measured using the Bradford assay [76] with 
bovine serum albumin (BIO-RAD, Hercules, CA, USA) as standard. 
The carbohydrate concentration of the mucus was assayed using the method described by Dubois et al. [77] 
and Kennedy and Pagliuca [78]. The assay was calibrated with known amounts of D-glucose. 
4.5. Electrophoresis 
Mucus samples were analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). They were 
run on discontinuous gels, based on the method of Laemmli [79] and the detailed protocols of Hames [80]. 
The gels contained 10% of acrylamide, and were 8 cm × 9 cm by 1.0 mm thick. The migration buffer 
consisted of 25 mM Tris, 192 mM glycine, pH 8.5. After migration, gels were stained using Silver Stain 
kit (Sigma, Saint Louis, MO, USA). Molecular standards (PageRuler™ Prestained Protein Ladder range 
10–250 kDa, Fermentas, Waltham, Massachusetts, USA) consisted in a mixture of eight recombinant, 
highly purified, coloured proteins with apparent molecular weights of 10 to 250 kDa. 
4.6. Lysozyme-Like Activity 
To detect lysozyme activity, inoculated Petri dishes were used as standard assay, 700 μL of 5 mg/mL 
of dried Micrococcus luteus cell walls (Sigma, Saint Louis, MO, USA ) were diluted in 7 mL of 0.05 M 
PB-agarose (1.2%, pH 5.0) then spread on a Petri dish. Four wells of 6.3 mm diameters were sunk in 
agarose gel and each filled with 30 μL of mucus. The diameter of the cleared zone of the four replicates 
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was recorded after overnight incubation at 37 °C and compared with those of reference samples 
containing known amounts of standard hen-egg-white lysozyme (Merck, Darmstadt, Germany). The 
effects of pH, ionic strength (I), and temperature were examined. The pH effect was tested by dialyzing 
the mucus in PB 0.05 M, ionic strength, I = 0.175, adjusted at pH 4, 5, 6, 7, 8 and by dissolving agarose 
in PB at the same I- and pH-values. The ionic strength effect was tested in PB 0.05 M (pH 6.0), adjusted 
at I = 0.0175, 0.175, 1.75. Agarose was dissolved in PB at the same I-values. The temperature effect was 
tested with incubations of samples (in PB, at pH 6.0, and I = 0.175) at 5, 15, 22, and 37 °C. 
4.7. Hemolytic Activity 
The rabbit erythrocytes (RRBCs) obtained by Istituto Zooprofilattico della Sicilia in Alsever solution 
(0.42% NaCl; 0.08% sodium citrate dihydrate, citric acid monohydrate 0.045%, 2.05% D-glucose pH 7.2) 
were washed three times with erythrocytes-Phosphate-buffered saline (PBSE) (KH2PO4 6 mM; Na2HPO4 
0.11 M; NaCl 30 mM; pH 7.4) and centrifuged at 1800 rpm for 10 min at 4 °C. Suspensions of RRBCs 
(2.5% in Tris buffer: Tris HCl 0.05 M, 0.15 M NaCl pH 8) were used to test the lysis of RRBCs by 
mucus. For the microplate assay 25 μL of mucus or serial (two-fold) dilution were mixed with an equal 
volume of the RRBCs suspension.in 96-well round-bottom microtiter plates (Nunc, Roskilde, Denmark). 
After 1 h incubation at 37 °C the lytic activity was recorded as the reciprocal of the highest dilution 
showing complete RRBCs lysis. 
For the quantitative hemoglobin release evaluation, one hundred microlitres of mucus in triplicate 
were mixed with 100 µL RRBCs suspension in glass tubes with U bottom, incubated for 60 min at 37 °C 
and then centrifuged for 5 min at 1500× g. One mL of Tris buffer was added to the supernatant  
in order to obtain an adequate amount of sample for spectrophotometric evaluation (541 nm) of the 
hemoglobin content. The degree of hemolysis was calculated by: [(absorbance of sample − absorbance 
of control)/absorbance of total hemolysis] × 100. Total hemolysis (100%) was achieved by adding  
100 µL of distilled water to the same volume of RRBCs suspension. 
Control erythrocyte suspensions were also prepared in the same medium and incubated as reaction 
mixtures: spontaneous hemoglobin release never exceeded 5% of the total release. For each experiment 
three samples were assayed. 
4.8. Cytoxicity Assay against the Tumor Cell Line K562 
The human erythromyeloid leukemia-derived cell line K562 were kindly provided by  
Dr. Domenico Schillaci (STEBICEF, University of Palermo) and was maintained for short time in RPMI 
1640 medium (Gibco, Grand Island, NY, USA) supplemented with 10% heat inactivated fetal calf serum 
(Flow Laboratories, Irvine, Scotland), gentamycin, streptomycin, and Hepes buffer (Boehringer 
Mannheim, Mannheim, Germany). 
Cytotoxicity effect of mucus against tumor cell lines was performed using a cytotoxic detection Kit 
(Boehringer Mannheim, Mannheim, Germany) based on determination of lactate dehydrogenase (LDH) 
activity released from lysed target cells [81]. The target cells were washed and suspended in PBS 
supplemented with 1% bovine serum albumin (PBS-BSA, 370 mOsm kg−1) at a concentration of  
105 cells mL−1. All tests were performed in triplicate with 104 target cells well−1 in V-shaped microplates 
(Nunc, Roskilde, Denmark) in a total volume of 200 µL. Plates were centrifuged for 1 min at 100× g 
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and incubated for 2 h at 18 °C. The plates were then centrifuged for 5 min at 400× g, and the release of 
LDH from lysed cells in 100 µL of supernatant from each well was determined by reading the absorbance 
at 490 nm in a microplate reader (Uniskan I, Labsystems, Helsinki, Finland). Spontaneous and maximum 
release were measured in 100 µL of supernatant from wells containing target cells only or target cells 
with 1% Triton X-100 (Sigma, Saint Louis, MO, USA). 
Spontaneous baseline LDH release from target (104 cells well−1) was used as controls. The values of 
the controls were subtracted from the degree of target cell lysis determined according to the equation: 
Percent lysis = (measured release − spontaneous target release)/(complete release − spontaneous 
target release) × 100. 
The living cells were observed through Nomarski differential interference contrast optics (DIC). 
Unless otherwise specified the cytotoxic reactions against tumour cells were carried out at 18 °C for 2 h. 
This is the optimal temperature for the molecule activity, for this short time the cells neither show any 
modifications nor do they die. 
In addition trypan blue exclusion test was used for dead cells determination by addition of 0.01% 
trypan blue to the medium. This test was also used to evaluate the cytotoxic activity against tumor cell 
lines, the dye was added into the reaction mixture after 2 h incubation. To show target cell death 
following an in vitro cytotoxic reaction, the trypan blue was added to the medium 20 min after the mucus 
were mixed with target cells. Samples of the reaction mixture were smeared on slides and examined 
under the microscope. 
4.9. Fractionation of Actinia Equina Mucus 
Although ultrafiltration is primarily a separation technique, under some conditions it can be used for 
the gross fractionation of proteins that differ significantly in size. Briefly, the 10 kDa Nanosep device 
has been inserted into one of the provided microcentrifuge tubes and 500 µL of mucus sample was added. 
The filter device was positioned into the centrifuge rotor with a counterbalance with a similar device. 
After 20 min of centrifugation at 6000× g the filtrate was transferred from the bottom receiver to a new 
tube for storage. The sample with low molecular mass was filtered through the membrane (10 kDa size pores) 
and collected as down fraction, while the component with higher molecular mass remained above the 
membrane and was collected as up and stored at −20 °C until the proteic concentration evaluation and the 
use for the assays. 
4.10. HPLC Size Exclusion Chromatography 
Mucus extract were subjected to size exclusion chromatography using BioSuite 250, 10 μm SEC,  
7.5 mm × 300 mm column (Waters, Milford, USA) on a HPLC system (Shimadzu Scientific Instruments, 
Columbia, MD, USA). The column was washed with Tris buffered saline (TBS) (150 mM NaCl, 10 mM 
Tris, pH 7.4). 200 μL of each sample were injected into the column which was eluted with TBS at a flow 
rate of 1 mL/min for 30 min. The chromatogram was recorded with a UV detector at 280 nm (mAU). 
The collected fractions were concentrated by centrifugation at 500× g with micro-concentrators (3 K 
Omega Centrifugal Devices Nanosep, Pall Corporation, Port Washington, NY, USA), and the final 
concentrated samples were stored at −80 °C until use. 
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5. Conclusions 
Compared with terrestrial ecosystem and organisms, marine ecosystems and biodiversity are largely 
unexplored and underexploited in terms of potential provision for biomaterials, food, energy, and 
beneficial services for humans. Here we showed the mucus of the cnidarian sea anemone A. equina 
might represent a novel source of bioactive molecules with potential applicative purposes in drug 
discovery and biotechnological processes. Further investigations will be required in order to isolate and 
better characterize the molecular effectors responsible for the observed biological activities of the sea 
anemone mucus. The search for novel biomolecules deserves the development of appropriate measures 
to strengthen the focus on untapped source organisms from marine environments. 
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